Neuroradiology: Page 49

GE promotes phase III flutemetamol results

By AuntMinnieEurope.com staff writers

GE Healthcare said pooled results from phase III brain autopsy and biopsy studies using its F-18 flutemetamol PET imaging agent demonstrated a strong concordance between the flutemetamol images and beta amyloid brain pathology associated with Alzheimer's disease.

September 10, 2012

Study queries effects of 7T MRI on the brain

By AuntMinnieEurope.com staff writers

Standard head movements made while exposed to electromagnetic fields produced by a 7-tesla MRI scanner seem to temporarily lower concentration and visuospatial awareness, according to a study published online on Monday in Occupational and Environmental Medicine.

August 29, 2012

Boston Scientific nets CE Mark

By AuntMinnieEurope.com staff writers

Interventional technology developer Boston Scientific has received the CE Mark for use of its Precision Plus spinal cord stimulator system in patients who are being treated with the system and need head MRI exams.

August 28, 2012

MRI scans undercut stenosis theory for multiple sclerosis

By Wayne Forrest

MRI has shown that changes in brain blood flow associated with vein abnormalities are not specific for multiple sclerosis and do not contribute to the affliction's severity, according to a study published online August 21 in Radiology.

August 28, 2012

EU demand for hybrid operating rooms looks set to grow

By AuntMinnieEurope.com staff writers

There will be an increased demand by hospitals in Europe to install hybrid operating rooms, finds a new report issued by market research company Frost & Sullivan.

August 13, 2012

IBA, Piramal sign deal on F-18 amyloid imaging

By AuntMinnieEurope.com staff writers

Radiopharmaceutical provider IBA Molecular and Piramal Imaging have announced an agreement under which IBA will manufacture and distribute F-18 florbetaben, Piramal's new diagnostic imaging agent, in the European and U.S. markets.

August 7, 2012

SyntheticMR signs software agreement

By AuntMinnieEurope.com staff writers

Medical imaging software developer SyntheticMR, a subsidiary of Accelerator Nordic, has signed an evaluation agreement with an MRI system supplier to evaluate its SyMRI software at selected clinics.

July 25, 2012

PiB, FDG-PET change diagnosis for dementia patients

By Wayne Forrest

A new study by Dutch researchers adds evidence that PET imaging with carbon-11-labeled Pittsburgh Compound B (PiB) and FDG can lead to early diagnosis of Alzheimer's disease and differentiate between specific dementias, especially when previous diagnostic certainty is low.

July 25, 2012

MRI shows fingolimod therapy helps multiple sclerosis patients

By Wayne Forrest

MRI scans have confirmed that the drug fingolimod reduced inflammatory lesion activity and brain volume loss in patients with multiple sclerosis. Results from the two-year, placebo-controlled trial were published online on 2 July in Archives of Neurology.

July 9, 2012

ESER sponsors emergency radiology course

By AuntMinnieEurope.com staff writers

The European Society of Emergency Radiology (ESER) is conducting a summer course on emergency radiology in Munich on 5-6 July.

June 26, 2012

MRI with gadolinium oxide particles finds more MS lesions

By Wayne Forrest

The combination of gadolinium and ultrasmall superparamagnetic iron oxide particles in patients with multiple sclerosis (MS) reveals 51% more active lesions in MRI scans than gadolinium alone, French researchers report in the July issue of Radiology.

June 26, 2012

ContextVision collaborates with Karolinska

By AuntMinnieEurope.com staff writers

Image enhancement developer ContextVision is partnering with the Karolinska Institute to develop new medical imaging tools.

June 25, 2012

Previous Page

Page 49 of 60

Next Page